RFC
HITK

Russell Frank Company’s HI-TECH PHARMACAL INC HITK Stock Holding History

Russell Frank Company’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,165
Closed -$266K – 3413
2013
Q3 		$266K Buy
6,165
+2,046
+50% +$78.3K ﹤0.01% 2684
2013
Q2 		$137K Buy
+4,119
New +$137K ﹤0.01% 2661

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Frank Company's HITK Position: Q4 2013 in Review

Russell Frank Company sold out of HI-TECH PHARMACAL INC (HITK) in Q4 2013, closing a stake of 6,165 shares — an estimated $266K sold.

Russell Frank Company first reported a position in HITK in Q2 2013 and held it in 2 quarters. The position peaked at $266K in Q3 2013. 101 funds tracked by Wall St. Rank hold HITK as of Q4 2013.

  • Russell Frank Company reported no remaining HI-TECH PHARMACAL INC position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 6,165 HI-TECH PHARMACAL INC shares in Q4 2013, an estimated $266K.
  • Russell Frank Company first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 2 quarters.
  • Russell Frank Company's HI-TECH PHARMACAL INC position peaked at $266K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.